Evidence map›Paper›PMID 40096449›Full record

ArticleSensors (Basel, Switzerland)2025

Performance Evaluation of a Mesh-Topology LoRa Network.

Thomas Gerhardus Durand, Marthinus Johannes Booysen

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thomas Gerhardus DurandDepartment of Electrical and Electronic Engineering, Stellenbosch University, Stellenbosch 7600, South Africa.ORCID 0009-0006-0350-8186
Marthinus Johannes BooysenDepartment of Electrical and Electronic Engineering, Stellenbosch University, Stellenbosch 7600, South Africa.ORCID 0000-0003-2817-2069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research into, and the usage of, Low-Power Wide-Area Networks (LPWANs) has increased significantly to support the ever-expanding requirements set by IoT applications. Specifically, the usage of Long-Range Wide-Area Networks (LoRaWANs) has increased, due to the LPWAN's robust physical layer, Long-Range (LoRa), modulation scheme, which enables scalable, low-power consumption, long-range communication to IoT devices. The LoRaWAN Medium Access Control (MAC) protocol is currently limited to only support single-hop communication. This limits the coverage of a single gateway and increases the power consumption of devices which are located at the edge of a gateway's coverage range. There is currently no standardised and commercialised multi-hop LoRa-based network, and the field is experiencing ongoing research. In this work, we propose a complementary network to LoRaWAN, which integrates mesh networking. An ns-3 simulation model has been developed, and the proposed LoRaMesh network is simulated for a varying number of scenarios. This research focuses on the design decisions needed to design a LoRa-based mesh network which maintains the low-power consumption advantages that LoRaWAN offers while ensuring that data packets are routed successfully to the gateway. The results highlighted a significant increase in the packet delivery ratio in nodes located far from a centralised gateway in a dense network. Nodes located further than 5.8 km from a gateway's packet delivery ratio were increased from an average of 40.2% to 73.78%. The findings in this article validate the concept of a mesh-type LPWAN network based on the LoRa physical layer and highlight the potential for future optimisation.

Indexed as

IoTLoRaLoRaWANLPWANmeshmulti-hopnetworkns-3sensor networks

Identifiers

PMID40096449
PMCPMC11902654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.